GHP 2017 Healthcare & Pharmaceuticals awards

Page 1

ghp

www.ghp-magazine.com

Research, Translation, Commercialisation

Specialised Hospital Coswig The Fachkrankenhaus Coswig Hospital a center for pneumology, allergology, respiratory medicine and thoracic surgery, which has a great and decades long experience in the treatment of bronchial and lung diseases. We profiled the firm and explore the secrets behind its success.

Best Payer Population Health Platform – USA

Dermatologist of the Year 2017 - London


Editor’s Note

, The healthcare and pharmaceuticals industry is as divergent as the entity and organisations performing within it, so much so that everyone deserves to be recognised for their everyday excellence. From the firms and organisations developing new and innovative ideas to save lives and change the way healthcare is delivered, to the stalwarts working behind the scenes to deliver remarkable care day after day, we are keen to turn the spotlight on everyone working to support the healthcare systems around the world. We at GHP Magazine are striving to showcase the talent and dedication which is apparent in this vast, tough industry. The 2017 Healthcare & Pharmaceutical Awards seek to chronical the individuals, departments and organisations, both corporate and public, that are working relentlessly throughout the industry. For the second year, GHP Magazine aim showcase the people behind the success stories. This involves a rigorous research process which uses a combination of online voting information, together with supporting evidence and the expertise of our in-house research team and judging panel. As such, please find the voting form below if you wish to make a nomination, and please feel free to spread the word about the awards and help us to highlight the leading lights in this industry. AI Global Media, Ltd. (AI) takes reasonable measures to ensure the quality of the information on this web site. However, AI will not assume any legal liability or responsibility for the accuracy, correctness or completeness of any information that is available through this web site. If errors are brought to our attention, we will try to correct them. The information available through the website and our partner publications is for your general information and use and is not intended to address any particular finance or investment requirements. In particular, the information does not constitute any form of advice or recommendation by us or any of our partner publications and is not intended to be relied upon by users in making or refraining from making any investment or financial decisions. Appropriate independent advice should be obtained before making any such decision. Any arrangement made between you and any third party named in the site is at your sole risk and responsibility.

2 2017 Healthcare & Pharmaceuticals Awards


Contents

* 4.

Best Specialist Pulmonology Hospital 2017 - Germany Specialised Hospital Coswig

8.

Best Laser Skincare Treatment Centre - London & Best Skincare Products - London Zaheda Skincare

,

10. Most Innovative Healthcare Platform 2017 GSI Health 12. Best Payer Population Health Platform – USA Casenet 14. Dermatologist of the Year 2017 - London The Harley Street Dermatology Clinic 16. Best Life Science CRO 2017 ChemPartner 18. Best Pharmaceutical Serialisation Consultancy 2017 3C Excellis Europe 20. Best Private Healthcare Service - Surrey The Parkside Suite* 22. Best Residential Rehabilitation Facility - Lehigh County Fellowship Community 24. Paediatric Pulmonologist of the Year 2017 - New Jersey Saint Peter 26. Best Provider of Oncology & Pathology Diagnostic Tools - USA & Medical Device CEO of the Year - USA IV Diagnostics Inc 28. Most Innovative Dental Professional Development Company - UK & Best Dental E-learning Provider - UK ProDental CPD Ltd 30. Best Pre-Hospital Care Provider - UK Medicare EMS Group UK Limited

2017 Healthcare & Pharmaceuticals Awards 3


HP170005

,

Best Specialist Pulmonology Hospital 2017 - Germany The Fachkrankenhaus Coswig Hospital a center for pneumology, allergology, respiratory medicine and thoracic surgery, which has a great and decades long experience in the treatment of bronchial and lung diseases. We profiled the firm and explore the secrets behind its success. All staff at the Fachkrankenhaus Coswig Hospital possesses a wealth of expertise and this is highlighted in the company’s motto: expertise. Thanks to the specialization and holistic approach provided at the hospital, excellent treatments can be offered, which deviates strongly from the performance spectrum of the regulatory providers. The hospital concentrates on specific treatments with enhanced specialisation and quality of care, meaning even the rarest diseases as well as the very seldom tumour of the mediastinum can be treated to a high standard at the hospital. There is a positive correlation between the number of cases and quality of results, which has been shown in a large number of studies. The results reveal shorter treatment periods and shortened operating times as well as lower complication rates. The Fachkrankenhaus Coswig currently has 165 fully-equipped beds as well as an oncological day clinic with 6 part-station seats. In the Fachkrankenhaus Coswig, during the years 2011 to 2016, an average of 750 patients were treated annually by thoracic surgery. In addition more than 120 anatomical resections were performed last year, of which 17% were reconstructive resections by broncho- and angioplasty as well as extended resections with intrapericardial vascular

supply, pericardial resection and pericardial reconstruction. But also in intensive care, about 750 cases were hospitalized in 2016 and in the department of Internal Medicine/Pneumology the case number in 2016 was around 6,000. The GKV-Spitzenverband, which is the central interest representation of the statutory health insurance funds at European and international level has demanded in its draft center agreement a much lower annual minimum number of 1.924 cases. The Fachkrankenhaus Coswig achieves excellent results with regard to possible complications.

Patients come from all around the world, including the U.S.A, China and Europe.

Highlighting its stature in the industry the Fachkrankenhaus Coswig possesses the world’s largest thorax-surgical laser center in which several thousand surgeries have already been successfully performed in patients from home and abroad using a special 1318 nm wavelength laser. With this laser system metastases in the lung can be removed from other tumours lying outside the lung tissue-protecting. A new development of the specialist hospital now offers the possibility of minimally invasive surgical procedures, such as the surgical treatment of the primary spontaneous pneumothorax or of peripheral solitary pulmonary arteries. Since this method can be used even at patients with a greater number of metastases the Fachkrankenhaus Coswig is still able to treat many patients with a prospect of healing, which could otherwise be classified as inoperable.

As a founder and heart of the competence network for pulmonary diseases in Saxony the Fachkrankenhaus Coswig now makes the existing relationships with individual clinics and established specialists available to all facilities in southeast of Germany. In order to ensure care at the patient’s place of residence, Fachkrankenhaus Coswig along with its partners has established the competence network for lung diseases which is being continuously expanded. It is intended to connect all those who have the same demand for the care of patients with pulmonary diseases as well as allowing network partners to utilise the expertise of the Fachkrankenhaus Coswig available to their patients. An example for this would be examining and evaluating patient records and submitting treatment recommendations.

4 2017 Healthcare & Pharmaceuticals Awards

In order to ensure the hospital keeps ahead of any developments within the healthcare industry and maintains its high quality of the treatment an interdisciplinary tumor board usually meets two times a week. In addition to the discussion of the treatment of patients with new diseases or after primary therapy the counselling of cases with recurrence and/or distant metastases takes place here.

Building on its sterling reputation the Fachkrankenhaus Coswig provides the three specialist departments required for comprehensive care of patients with lung diseases. In the department of Internal Medicine/Pneumology, there are patients treated with the entire spectrum of acute and chronic diseases of lung and bronchial tubes as well as patients with sleep-related respiratory disorders. In accordance with the mission statement of the Fachkrankenhaus the patient is the focus of staff’s efforts with individuality. Additionally the thoracic surgery department treats all lung diseases, the chest wall, the medial, the ribs, the pleura and the diaphragm, using up-to-date surgical procedures. For this purpose, minimally invasive surgeries as well as conventional anatomical resections of the lung carcinoma are performed. In addition complex thoracic wall reconstructions are performed after rib-division or breastbone resections as well as the stabilization of rib-series fractures with the most modern osteosynthesis procedures. For the better classification of lung cancer by resection of the lymph glands of the mediastinum, the specialist hospital developed for the first time the video-assisted mediastinal lymphadenectomy in combination with an intraoperative neuromonitor of the vocal cord nerve to better protect the nerve at the ESTS in Naples. The national and


g Best Specialist Pulmonology Hospital 2017 - Germany

Company: Specialised Hospital Coswig Contact: Antje Richter Email: richter.antje@fachkrankenhaus-coswig.de Drewes@fachkrankenhaus-coswig.de (chief physician Steffen Drewes, department of thoracic surgery) Address: Neucoswiger Str. 21, Coswig, D-01640, Germany Phone: 03523 65116 Website: www.fachkrankenhaus-coswig.de

2017 Healthcare & Pharmaceuticals Awards 5


,

international laser center is an important component of this holistic treatment segment. Regarding the Department of Anaesthesiology the range of services offered is distinguished by, among other things, the differentiated ventilation technology including highfrequency jet ventilation, the implantation of venous port systems for oncological polychemotherapy, as well as the provision of acupuncture techniques for analgesia, postoperative vomiting and addictive weaning. Employeesin this department hold many years of experience in the treatment of severe acute and chronic diseases of the lungs. Differentiated invasive and non-invasive ventilation supports patients breathe independently. Patient’s medical care is completed carers and nurse, alongside services of physiotherapy, psychological service, social services, pastoral care, speech therapy and nutritional advice. Additionally an on-site diagnostic and treatment service is available to the patient on site. Boasting a sterling reputation and a wealth of qualifications it is also the numerous certifications that the Fachkrankenhaus Coswig has to offer which helps to make it stand out as one of the best hospitals in the trade. This includes the certificate as a center of excellence for thoracic surgery – only one of 14 thoracic centres in Germany, as well as the outstanding certification as a lung cancer center. Among its services is the hospital’s Disease Management Programs (DMPs) which are structured treatment programs for chronically ill people. The objective of the DMPs is to improve the treatment process and the quality of care for patients. The Fachkrankenhaus Coswig has been taking part in the DMPs Asthma and COPD since 2008. In this context, Fachkrankenhaus Coswig provides its expertise to clients, the practicing physicians and, as a result, the patient. By means

of up-to-date information and enlightenment, the patients are integrated into the decisionmaking process for individual diagnosis and therapy planning. Communication is the key with regard to the healthcare of patients and the trusting contact with the relatives and the selfhelp groups is also part of the work. All treatment processes are patient-oriented since Fachkrankenhaus Coswig is a consultancy and service center for patients and relatives. In addition to an individual transfer management from the clinic to the domestic areas patients are offered services such as acupuncture, pain therapy, selfhelp groups for long-term oxygen therapy or smoking counseling/cessation. Always looking to provide the best possible service, the patient is at the center of the hospital’s medical efforts. Patients are respected as an autonomous personality who is integrated into the investigation and treatment process as an independent agent. Medical actions and decisions are based on humanistic principles. They are based on many years of professional experiences as well as on modern, evidence-based guidelines oriented medicine, including psychological and physiological aspects. The atmosphere in the Fachkrankenhaus Coswig is collegial, case-related and interdisciplinary, which is reflected in the daily case discussions of pneumologists, thoracic surgeons and anaesthesiologists. This is highlighted by the results of the patient questionnaires, which shows that 93% of the patients would recommend the Fachkrankenhaus Coswig to their relatives and friends. In order to ensure excellent care for the patients in the long term, Fachkrankenhaus Coswig is an Academic Teaching Hospital of the University Clinic Carl Gustav Carus Dresden, which has been involved in the training of students for many years. It also offers positions

6 2017 Healthcare & Pharmaceuticals Awards

for physicians for professional development, for a clinic trainee programme and for the practical year. The Fachkrankenhaus, with all its departments, also acts as an institution, offering objectiveness of clinical research to students interested in doctoral subjects. For this reason, the chief physicians of the Fachkrankenhaus Coswig have appropriate training authorization in their respective fields such as internal medicine, pneumology, surgery with an emphasis on thoracic surgery as well as anaesthesiology and intensive care medicine. Interestingly the Fachkrankenhaus Coswig is not only a source of care and training but also engaged in clinical research. It is a center of multicentric therapies of the phases II to IV and works on its own scientific questions. As a member of many companies, associations and unions, Fachkrankenhaus Coswig has the opportunity to play an active role in health care. In particular the idea of networking with other service providers as well as the mutual exchange is used for the placement and accompaniment of relevant topics – even beyond the borders of Saxony. The management of the Fachkrankenhaus Coswig is represented as a member of the Hospital Society of Saxony (KGS), the Association of Pneumological Clinics (VPK) and the Association of Hospital Directorates. Ultimately the Fachkrankenhaus Coswig focuses on the guiding principles in everyday clinical practice, concentrating on the implementation of values or intentions, such as quality, the will to help build trust, its strengths through networking and to promote partnership and visibility, and this will remain the firm’s hospital’s ongoing focus as it looks towards a bright and exciting future.


g Best Specialist Pulmonology Hospital 2017 - Germany

2017 Healthcare & Pharmaceuticals Awards 7


HP170020

,

Best Laser Skincare Treatment Centre – London & Best Skincare Products - London Zaheda Skincare was founded by Zaheda Hafez, who possesses a wealth of experience in the skin care industry. Zaheda tells us more about her company, discusses her skin care range and procedure, and how this makes the company successful. Inspired by the clients she has advised over the years, Skin Expert and Founder Zaheda Hafez applied two decades of expertise, in collaboration with leading skin care scientists to create ZAHEDA SKINCARE. A high quality science-led skin care range, formulated with a unique blend of marine and botanical actives that work synergistically to produce impressive results. Zaheda discusses the principle ingredient of her products with us, and explains what research went in to making the best product. “The principle ingredient in our products, Wakame Sea Kelp,

Phytassence Wakame is derived from an exotic kelp (sea algae) and has been shown to help inhibit an enzymatic reaction that breaks down the skin’s supply of hyaluronic acid. Scientific studies have shown hyaluronic acid to improve skin hydration and stimulate the production of collagen and elastin in the skin, reducing the appearance of fine lines and wrinkles and help keep the skin more plump, supple firm and youthful.”

“Following The 3 Steps Skin Care Schedule, clients should choose 3 products in total. One from 1 to cleanse, one from 2 to exfoliate, and one from 3 to moisturise. Clients should then simply cleanse, exfoliate and moisturise twice a day, to reveal and maintain more glowing youthful looking skin.”

To ensure excellent results she offers clients guidance on their use. Zaheda outlines on the procedure which helps to get the best results from her products, setting out a 3-step plan.

• • • •

From the Zaheda Skincare range clients can choose the best products for their skin type.

• • • • •

Deep Sea Cleanse (1a) Ocean Tone (1b) Ultra Smooth Sea Polish (2) Sea Collagen Marine Serum(3a) Marine Fluid Shine Free (3b) Marine Boost Super Serum (3c) Ultimate Youth Lift (4a) Ultra Light Derma White (4b) Sea Collagen Marine Body Serum (5)

Ultimately, having previously founded The Laser Treatment Clinic in Harley Street London, there is a lot to be optimistic about. Outstanding products are vital to ensuring a successful business, and with such a diverse range, Zaheda Skincare is guaranteed to attract more clientele, and build upon the solid foundations already laid out.

8 2017 Healthcare & Pharmaceuticals Awards


g Best Laser Skincare Treatment Centre – London & Best Skincare Products - London

“The 3 Steps Skin Care Schedule - It’s my secret to Beautiful Skin” Zaheda Hafez Skin Expert and Founder

Company: Zaheda Skincare Contact: Zaheda Hafez Website: www.zaheda.com Address: 1 Harley Street, London, W1G 9QD, UK Phone: 020 7307 8712

2017 Healthcare & Pharmaceuticals Awards 9


HP170021

,

Most Innovative Healthcare Platform 2017 GSI Health unites patients, providers, and payers of all kinds, supporting collaborative, all-inclusive healthcare for effective population health management with complex populations. The team at GSI Health discusses the company’s success and award-winning population health management solution. GSI Health’s innovative solutions deliver the bigger picture of patient care, moving beyond just medical or claims data to integrate behavioral information and social determinants of health from across the community so that care teams can manage, analyze, and engage with patients in real time as they move through the care delivery system. Care teams gain keener insights that improve the quality of care and the overall health of the population, enabling organizations to achieve better outcomes while improving ROI. Attributing a variety of factors to the company’s success, GSI Health’s founder and CEO LeRoy Jones explains what makes the firm unique and how the company aims to differentiate itself from other similar firms within the industry. “At GSI Health, we believe in a corporate vision of Healthcare Solved. That is, we have a corporate mission to deploy technology that enables seamless coordinated care across the continuum, thereby treating the whole person, and healing the whole population. We believe we are able to distinguish ourselves from our competitors by delivering a population health management solution that combines care coordination with rich analytics and deep interoperability in a single integrated platform. Our team’s expertise and worldclass support helps our clients

navigate the evolving landscape of value-based healthcare models to ensure that their population health management initiatives continue to meet their needs.”

GSI Health strives to keep pace with the rapidly changing healthcare industry, driving innovation with healthcare delivery now and into the future.

A sign of its success, GSI Health’s innovative work has been independently validated through third-party research organizations and is being applied to programs that are helping improve outcomes for some of the population’s most vulnerable patients.

“Payment innovations within the industry have given rise to our technological innovations around collaborative care and care-delivery optimization. Our solutions are helping establish new paradigms, such as support for distributed, multidisciplinary care teams, and multi-provider longitudinal care plans for patients. We have been on the vanguard, bringing analytics to the point of care and connecting insights with care delivery in a way not previously done. We are a part of the emerging discovery of what care protocols are empirically useful in a collaborative care model, which will transform what we currently think of as evidencebased medicine.”

“At GSI Health, our work successfully supporting innovative programs focusing on integrated care, such as the Medicaid Delivery System Reform Incentive Payment (DSRIP) program and others is enabling providers to assume more risk for managing their populations, and meet the challenges of moving to a valuebased model, which is the future of the healthcare industry. “As the first permanent payment reform for safetynet populations, the DSRIP program is influencing healthcare payment programs throughout the nation. Our platform is a pioneering technology for the DSRIP program, supporting the biggest public hospital system in the country and the largest performing provider system (PPS) in New York State’s DSRIP program. Our quick and successful support of the DSRIP program for our clients has escalated them as leaders in DSRIP progress.”

10 2017 Healthcare & Pharmaceuticals Awards

GSI Health is poised to build on the success of its previous achievements. “We have been able to stay a leader in this emerging field because we have accurately predicted the market’s key needs, and their correct trajectory of relevance, enabling our customers to be equipped to consistently perform well in a rapidly evolving environment. Healthcare payment reform is driving our growth, and the move to replacing volume-based compensation with value-based compensation will continue to fuel our leadership for years to come.”

LeRoy Jones Founder and CEO


g Most Innovative Healthcare Platform 2017

Company: GSI Health Email: info@gsihealth.com Address: 1735 Market Street, 53rd Floor, Philadelphia, PA, 19103, USA Phone: 1-888-206-4237 Website: www.GSIHealth.com

2017 Healthcare & Pharmaceuticals Awards 11


HP170030

,

Best Payer Population Health Platform – USA Casenet delivers a population health and care management platform to meet the unique care coordination needs of health plans, government-sponsored organizations and other risk bearing entities. CEO Peter Masanotti tells us more about the firm and the services it offers. Drawing on over 15 years’ experience in the population health and care management industry, Casenet’s mission is to be the single, unified population health platform that enables our clients to deliver better health outcomes at appropriate costs. Led by a team that combines a passion for healthcare and deep domain expertise with proven track records of delivering powerful enterprise software solutions and delighting customers, the firm works hard to achieve its goals and provide its clients with the very highest possible standards of service, as Peter explains. “Here at Casenet, we align data and resources, so our clients can manage care with confidence. Our configurable, scalable population health management platform unites disparate data sources, enabling a more comprehensive view of patients and citizens. As a result, our clients can improve the delivery of care at appropriate costs. “The Casenet population health and care management platform scales to meet unique customer requirements and is configurable to satisfy specific state and federal government as well as business needs. The Casenet team works with clients to deliver a platform that meets their current and future needs. Fundamentally, our team’s sole focus is on population health and care management solutions and this

singular focus is rewarded by the high customer satisfaction rating given to us by our loyal clients.” When operating in such a fast paced market, staying at the forefront of the latest industry developments is vital. Thanks to its vast knowledge of the market, Casenet has a strong understanding of the latest changes to the market, and therefore Peter is eager to emphasise these and how they impact his firm. “As EHRs and EMRs are more widely implemented, there is a greater need to make the data within EMRs/EHRs available and actionable across systems. Integrating electronic records with a care management system provides synergy on many levels: among individuals and teams; payers and providers; and within clinical, IT, financial and other stakeholders. Centralized data mined from EHRs/EMRs trigger care that is timely, comprehensive and considerate of all member health circumstances. Workflow efficiency, in tandem with utilization and care management, improve the health of patients and citizens, who receive the best possible care each time, and reduce costs by ensuring only appropriate, non-duplicative care is provided. “The current changes in policy have further supported the Casenet mission of enabling our clients to deliver better health outcomes at appropriate costs. No matter what the changes in

12 2017 Healthcare & Pharmaceuticals Awards

the health policy and processes today, the most vulnerable populations and the chronically ill will continue to need care coordination programs to ensure appropriate use of resources and positive health outcomes.” To adapt around these latest policy developments, Casenet has recently developed a solution to help improve provider engagement and reduce the administrative burden placed on providers as a result of the prior authorization process. The TruCare ProAuth™ solution enables providers to submit and track authorizations via an online portal with the goal of reducing faxes and increasing automation. TruCare ProAuth streamlines the authorization submission process and enables providers to more quickly and easily receive authorization decisions thus enabling providers to spend less time on paperwork and more time with patients. It is this focus on client satisfaction that defines the firm’s achievements, as Peter discusses. “Overall, Casenet’s success is tied to its clients’ success. Our team works hard to serve each and every one of our clients every day. There is no better measure of how hard they work than direct client feedback. In 2017, independent research firm, KLAS, selected Casenet as the 2017 Best in KLAS Care Management Vendor award winner. This recognition is especially rewarding because it is based on the research KLAS did

directly with Casenet and other industry clients. “In addition to our KLAS award, Casenet received a 93% customer satisfaction rating from its internally managed client customer satisfaction survey. Client needs are prioritized when developing TruCare, ensuring that TruCare grows in alignment with them.” Moving forward, Peter believes that the next game changing healthcare innovation will be universal longitudinal care records that travel with patients and provide ubiquitous access to care information. Such an innovation requires advanced information integration to deliver 360-degree, longitudinal views of patients regardless of location, payer or provider. Unifying all health information along a patient’s health journey will allow care teams to achieve the best quality care and outcomes. As such, he is keen, in his concluding comments, to highlight how Casenet will continue to build upon its technical offering to provide clients with the solutions they need. “Looking to the future, we believe that technology investments that focus on reforming the care and management of patients with the most complex conditions and empowering the healthy to stay healthy is the future direction of the healthcare industry. Casenet is well positioned to participate in this evolution of the healthcare industry.”


g

Best Payer Population Health Platform – USA

Company: Casenet Contact: Peter Masanotti, CEO Email: pmasanotti@casenetllc.com Address: 36 Crosby Drive, Bedford, MA, 01730, USA Phone: 001 781 357 2700 Web Address: www.casenetllc.com

2017 Healthcare & Pharmaceuticals Awards 13


HP170006

,

Dermatologist of the Year 2017 - London The Harley Street Dermatology Clinic was founded by Dr Adam Friedmann to establish a leading service provider in the field of private dermatology in London. There are comfortable consultation rooms and facilities to provide treatments such as cryotherapy and skin surgery on site. We profiled the firm to find out a bit more about the clinic’s success.

The Harley Street Clinic has a team of eight fully qualified, highly trained expert dermatologists who can identify and treat the rarest and most difficult to diagnose skin, hair, nail and genital conditions. The firm’s consultants are trained in adult and paediatric dermatology, treating patients of all ages from all around the world. It has become one of the biggest providers of private medical dermatology in the country and are extremely highly rated amongst our clients. Adam gives us an overview of some of the services that the facility provides. “In addition to treating physical symptoms, we also provide care to help with the other effects that these conditions can have on your health and wellbeing. The clinic has a clinical psychologist to provide emotional support and offer advice on living with a skin condition. Having a skin condition or chronic dermatological problem can have a big impact on the quality of living, and it can leave you feeling self-conscious or anxious when you meet other people. Our experienced psychologist can help you to adjust to your diagnosis and provide tools to help you cope with your symptoms and the struggles that come from.” To be successful, a company must have an overall mission and goals which staff aspire to reach and fulfil. Adam outlines

the clinic’s overall mission, with the company aiming to be in a position to expand again, having recently done so.

diagnosis, appropriate treatment and management plan in such a way that suits an individual’s personal needs.

“At the Harley Street Clinic, our mission is to become a renowned dermatological centre of excellence. Our consultant dermatologists specialise in the medical aspects of skin disease and are able to treat conditions ranging from autoimmune diseases such as lupus to skin cancer. Our service is positioned as a premium experience and the reputation is upheld by delivering an excellent patient journey from booking, to consultation to the completion of treatment. We have recently expanded and been going through a refurbishment- the finishing touches are still being worked on, but we are all very proud of our new consulting rooms. There are further expansion plans for December this year with the acquisition of another suite of medical rooms. We plan to provide more medical dermatological services in-house, reducing the need to use local trusted providers and ultimately deliver a more efficient patient service.”

“Offering a variety of services, our clinic leans towards the medical side of dermatology, and all consultants are qualified skin surgeons able to remove cancers, moles and other lumps and bumps from the skin for medical purposes, but occasionally undertake cosmetic treatment such as a small mole removal. They spend their professional life exclusively treating skin disease. Consequently, this gives them the highest level of expertise and experience in the field of dermatology. Having done research and publishing papers in medical dermatology, most have undertaken research in their field of interest and published their findings in international journals, making them world authorities.”

Adam states how the expertise of the clinic’s staff helps it to overcome most of the challenges that present themselves within the industry and how they are always looking to learn. Only top and fully qualified consultant dermatologists are employed to guarantee patients can receive a

14 2017 Healthcare & Pharmaceuticals Awards

Keeping up to dates with developments within the industry and staying ahead of any advances which may affect the clinic, Adam notes that all of the facility’s consultants attend events around the world in order continue their professional development. The clinic and its staff are always looking ahead to the bigger picture, and Adam concludes by explaining how important the impact of skin medication can have, as this is the foundation that the clinic was built on.

“All of our consultants attend continuing professional development events across the globe. With the advent of the biological drugs used to treat psoriasis (amongst other conditions), this has been the biggest development in dermatology over the last 20 years. Psoriasis is now a condition that can be cleared almost completely with injections of these drugs, and very excitingly, the same therapies are now beginning to emerge for the treatment of eczema. We now see a large number of patients who are seeking these treatments, and of course we are able to provide them. “Overall, the improvement in life quality brought about by these medications highlights the impact that severe skin disease can have on life, and how important it is to be able to treat it satisfactorily. This is the founding principle by which the Harley Street Dermatology Clinic was established and by which our consultants continue to practice.”


g

Dermatologist of the Year 2017 - London

Company: The Harley Street Dermatology Clinic Contact: Adam Friedmann Email: dr.friedmann@hs-dc.co.uk Address: The Harley Street Dermatology Clinic, 35 Devonshire Place, London, W1G 6JP, UK Phone: 0845 154 3260 Website: www.hs-ds.co.uk

2017 Healthcare & Pharmaceuticals Awards 15


HP170008

,

Best Life Science CRO 2017 ChemPartner is a leading research organization providing high-quality and cost-effective services for the biopharmaceutical industry. We invited Livia Legg, Chief Commercial Officer, to discuss the services the company offers and explore the secrets behind its success. As a world-class organization with exceptional scientists and experienced leaders, ChemPartner understands what it takes to be the partner of choice for drug discovery and pharmaceutical development. As global pharmaceutical and biotechnology companies look for service organizations who can provide intellectual input, along with technical expertise, ChemPartner stands out to be not only a global contract research and manufacturing organization (CRO/CMO), but also a true pharmaceutical research alliance partner. Livia Legg, Chief Commercial Officer, discusses the firm’s specific focus.

Experience is a key factor in the success of ChemPartner. The company and its staff of experts are fully dedicated to helping clients reach time-sensitive goals and to fulfill high expectations, something Livia explains.

“Since its inception in 2002, ChemPartner has evolved from a pure chemistry provider located in China to a global, drug discovery and development service organization with laboratories and business operations in China, the US, Europe, and Japan. In addition to Chemistry, our portfolio of services includes Biology, Biologics, Drug Metabolism Pharmacokinetic (DMPK), and Chemical Manufacturing and Control (CMC) for both small molecule and biologic therapeutics. Our growth and transformation are fueled by successfully operating a business model based on operational excellence, customer satisfaction, and value creation.”

As with any major company, ChemPartner must offer something unique in order to attract business and clients. ChemPartner does this by working cohesively, both internally and with clients, and by boasting a high-quality team collaborating on a worldwide basis as Livia points out.

“Over the past 15 years in business, ChemPartner has acquired deep institutional knowledge and experience as well as demonstrated a track record of success. Our leadership team has breadth and depth of knowledge in drug discovery gained through many years of pharmaceutical industry experience. Our scientists provide intellectual input to our clients and jointly solve complex scientific and technical problems.”

“ChemPartner is comprised of experienced, dedicated, and passionate individuals with a love for science and commitment to service. Our motto at ChemPartner is One Team, One Success. This operational philosophy guides how we think and act, and is evident in the way we communicate, coordinate, and collaborate

16 2017 Healthcare & Pharmaceuticals Awards

with our colleagues and clients. Additionally, we balance the benefits of global reach with the need for local presence by operating laboratories and offices in major pharma/biotech hubs throughout the world. This enables us to develop face-toface relationships, establish mutual understanding and trust, form productive and long-term partnerships, and develop crossfunctional ChemPartner-client teams.” With a dynamic force of synthetic and medicinal chemists, ChemPartner continues to be a leading chemistry service organization. The company has successfully designed and synthesized millions of molecules for hundreds of pharmaceutical and biotech companies worldwide. However, ChemPartner does not just focus on chemistry. “Chemistry is a cornerstone business for ChemPartner, and we continue to invest in our chemistry and knowledge-based drug design laboratories in China and the US. Leveraging our expanded service portfolio, we couple chemistry together with our biology and DMPK capabilities to deliver a truly integrated solution for discovering chemical “hits” and transforming them into candidate drugs. ChemPartner’s rapid growth in biologics mirrors the industry trend, and our biologics team has the expertise to discover,

express, purify, and analyze monoclonal antibodies and recombinant proteins. “As our clients’ programs progress to first-in-human studies, our CMO companies, China Gateway Pharmaceutical Development and China Gateway Biologics, seamlessly transfer projects from late preclinical into early stage clinical through their pharmaceutical development, process development, and cGMP manufacturing services.” Because the pharmaceutical research and development landscape is constantly evolving, ChemPartner must remain ahead of the curve. Livia explains that ChemPartner stays on the leading edge through continued advancements. “As a science-driven and technology-based CRO, we are committed to providing innovative solutions to serve the rapidly changing needs of our clients. We build for the future by remaining on the forefront of science and technology. To this end, we listen to our clients, participate in industry meetings, and consult our Scientific Advisory Board to identify emerging trends and ensure we remain current and competitive. Further, we attract talent with key expertise and develop future leaders through mentoring, training, and educational programs, including an international visiting scientist program.”


g Best Life Science CRO 2017

Lastly, with ChemPartner aiming to capitalize on its recent success, Livia confirms that the strong organization will continue to work hard and smart to provide high-quality services to their clients and sustain a successful future for the company. “ChemPartner’s success is powered by the success of our clients. We will continue to align our goals, develop innovative solutions, and execute tailored strategies to enable our clients to successfully bring new medicines to market.”

Company: ChemPartner Contact: Sarah Stapleton Email: sstapleton@chempartner.com Address: No.5 Building, 998 Halei Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai 201203, China Phone: 0086 21 5132 0088 Website: www.chempartner.com

2017 Healthcare & Pharmaceuticals Awards 17


HP170012

,

Best Pharmaceutical Serialisation Consultancy 2017 3C Excellis Europe, a subsidiary of US-based Excellis Health Solutions, is a leading European specialised consultancy. Christoph Krähenbühl provides us with an insight into the company and its success. 3C Excellis’ particular focus is on serialisation and traceability in the pharmaceutical industry, provided within the wider expertise of a business and information technology consulting company. The company provides strategic business advice, solutions and products for clients within the pharmaceutical, medical device and consumer packaged goods industries. In addition, 3C Excellis is also a preferred business partner for many of the leading fortune 2000 companies because of its vertical industry knowledge and commitment to delivering excellent client service. Christoph outlines the overall aims of the company and provides us with more details of how the team plans to reach its goals. “Here at 3C Excellis, our aim is to provide value beyond compliance. Every employee helps our customers to define their serialization related enterprise strategy and integrate track and trace in their business architecture, identify and implement the right solutions to make their program a success. This approach is rooted in years of practical experience and always framed from the client’s perspective rather than the classic solution provider’s perspective.

“All of the team place great faith on our solution and vendor independence, as we recognise that different customers may have very different needs. A solution that is perfect for one customer may be the wrong approach for a company that has different requirements and faces different constraints. Through a rich set of tools, methodology and products that the team have developed, we are uniquely placed to ensure a successful outcome, with the critical and ever shortening timelines framed by the urgent regulatory requirements.” Following on from explaining the company’s mission, Christoph is keen to discuss 3C Excellis’ most significant breakthrough. Integrating with a US based company is something he highlights straight away, as well as noting excellent customer satisfaction, and a full understanding of the technology systems required to offer a quality service. “Over the last 18 months, we have successfully completed the full integration of our European organisation with US-based Excellis Health. This now places us in the leadership position of being able to combine the learning from the US in areas such as Aggregation and Supply Chain Management with the unique EU-FMD expertise to

18 2017 Healthcare & Pharmaceuticals Awards

bring an unbeatable offer to our clients. As an organisation, we bring a deep understanding of all aspects of the full serialisation technology stack, from line level to global event repositories and external compliance reporting to authorities; thanks to our extensive hands-on implementation experience we also recognise the importance of the many and complex areas beyond the coding and IT systems that need to be covered in order to deliver a successful project outcome.” Establishing themselves as a leading company in the pharmaceutical industry, Christoph tells us what 3C Excellis does to ensure it stays ahead of developments, and how staff adapt to any potentially challenging issues. “Always looking for the next development, staff actively monitor and interpret the everchanging regulatory requirements for our internal use and also to be able to offer our clients the Regulatory Requirements Radar product. Additionally, the team work actively in industry associations, helping shape the developments and collaborate with solution providers which offers us insights from all sides. “Regarding our hiring structure, we invest in recruiting and

training young associates who can benefit from the experience of our established practitioners. We are also productising our offering including products such as our Passport to Europe, our Regulatory Requirements Rader, our CMO on-boarding program and our serialization health check.” Looking ahead, Christoph predicts what the future has in store for the firm, as 3C Excellis Europe looks to capitalise on its previous achievements and resulting success in this competitive industry. The global reach of 3C Excellis Europe will help the team delve into new areas of expertise and regions, something staff can be very happy about. “Moving forward, the team will continue on an exciting program of expansion, through organic growth as well as strategic acquisitions. Leveraging our global resources, we are expanding into new areas and continue developing new products. “Ultimately, 3C Excellis Europe will continue to develop to be able to offer our current and prospective customers the best possible help and support in overcoming the enormous challenges that the industry faces.


g

Best Pharmaceutical Serialisation Consultancy 2017

Company: 3C Excellis Europe Contact: Christoph Krähenbßhl Email: getsecured@3cexcellis.eu Address: 3C Excellis Europe, Leek, Staffordshire, ST13 6LP, UK Phone: 07765 221 298 Website: www.3cintegrity.com

2017 Healthcare & Pharmaceuticals Awards 19


HP170019

,

Best Private Healthcare Service - Surrey Operating within Frimley Park Hospital, the Parkside Suite offers a wide range of private healthcare services, the cost of which helps support the NHS services provided within the hospital. We spoke to Annette Godolphin to learn more about how this is achieved.

The Parkside Suite, Frimley, is an exceptional private unit within Frimley Park Hospital, part of Frimley Health NHS Foundation Trust in Surrey. Annette talks us through what patients can expect from this award-winning unit. “The Parkside Suite is a dedicated private ward situated within an NHS Foundation Trust, with all profits generated by a patients’ stay re-directed to enhance NHS services within Frimley Health NHS Foundation Trust. The Suite has a dedicated multi-cultural team who are passionate about the care they deliver. This is at all levels and includes housekeeping; catering; finance and bookings; and our clinical teams of healthcare assistances, nurses, sisters and consultants. Each team prides themselves on the care they deliver and all are conveniently located with the Parkside Suite.

“Each and every one of our patients at the Parkside Suite can expect healthcare of the highest quality, and feel secure in the knowledge that some of the region’s finest specialists work within the hospital. Thanks to our unique location, our patients have access to the most up-todate technology, treatment and scanning facilities.” “Staff really make the healthcare experience; however, we need to ensure that we are providing patients with the most cutting edge technological healthcare solutions, in order to make sure their recovery is properly monitored and controlled. To achieve this, the unit has access to a variety of facilities within the hospital, including operating theatres which are fully equipped to undertake a wide range of surgeries. These include specialised orthopaedic procedures, which are carried out in our clean-air theatre. As part of

our dedication to innovation, five of our private rooms are equipped with Draeger cardiac monitors for our cardiology patients.” Working with a wide variety of patients, the unit is keen to offer each and every one of them the highest level of support, as Annette is keen to emphasise. “Ever flexible, we offer care to both insured and self-funding patients. Private medical treatment is a personal choice and we find that young and old, professional or retired individuals want to take advantage of shorter waiting times, flexible appointments and continuity of care.” “To ensure everyone we treat receives the support they need, our mission is to guarantee our patients’ and their families’ journey is of the highest standard, whether they are with us for a day procedure or for a more complex case we want to provide transparent and understanding care for all. Our detailed ‘patient pathway’ allows patients to understand the care they will receive. This includes our team liaising with insurance companies on the patients’ behalf and assisting with price and care packages that are available.” “Once a patient has had their procedure booked, they will be contacted by the bookings team who will inform them of pre-op appointments, details of admission and expected length of stay. After their procedure,

20 2017 Healthcare & Pharmaceuticals Awards

should they require it, we have specialist teams within Frimley Park Hospital who can assist with, occupational therapy, dietetics, speech and language therapy, pain management and post-operative care.” “With Frimley Health NHS Foundation Trust acquiring Wexham Park Hospital, we have absorbed their private unit, formerly named the Paragon Suite. This has been rebranded as the Parkside Suite, Wexham, and a major refurbishment of this unit will provide patients in the Berkshire area with a further choice when booking private treatment. We understand the constant need to improve the services we provide. With this in mind we have introduced a private GP Service. Patients can make flexible appointments with our in house Private GP, they assist with various health issues for all the family including; health checks, vaccinations, immunisations injections and emergency prescriptions. We also offer complimentary initial cosmetic consultations, the most popular of which are; varicose veins, breast augmentations, tummy tucks, mole removal and blepharoplasties.” Ultimately, the Parkside Suite has already achieved extensive success, however as Annette is keen to highlight, the team will not be resting on its laurels and is keen to continue providing the exceptional standard of care on which the unit has come to pride itself.


g

Best Private Healthcare Service - Surrey

“Overall, the future is exciting for the Parkside Suite, as we have invested greatly into the dedicated private units at both Frimley and Wexham. Including complete refurbishment of both sites. We are delighted that plans to build a new Heatherwood Hospital, located half way between our current units in Ascot, have been approved by local planners, subject to conditions. This will include an eight-bed private patients’ suite including outpatients and diagnostics services. Already this year, we have great support from our consultants to work within this new facility, providing the Ascot area with a new hospital fit for the 21st century.”

Company: The Parkside Suite Contact: Annette Godolphin Email: Annette.Godolphin@fhft.nhs.uk Address: Parkside, Frimley & Wexham Private Patient Suites, Frimley Health NHS Foundation Trust, Frimley Park Hospital, Surrey, GU16 7UJ, UK Phone: 01276 604895 Website: www.parkside-suite.org.uk

2017 Healthcare & Pharmaceuticals Awards 21


HP170013

,

Best Residential Rehabilitation Facility – Lehigh County Fellowship Community is a continuing care retirement community that provides Christcentered caring for seniors at every stage of life. We profiled the community and CEO, Robert Zentz provides us with a breakdown of the organisation’s mission and overall targets. Fellowship Community is a nonprofit organization designed for aging in place, although President/CEO, Robert Zentz, adheres to his philosophy that seniors should come to Fellowship Community to wear out and not rust out. Never alone, residents enjoy loving friends, spiritual guidance, explore great opportunities and receive the best healthcare, all in the space of one beautiful campus. The community has won many awards, and Fellowship Community offers residents beautiful independent living town homes and apartments, state-licensed personal care with a specialized memory care unit, as well as a nursing care centre which provides short-term rehab and post-acute care.

At the age of 80 years old, Mr. Zentz is an active community leader, serving as Chairman of the board for a local hospital and he is also the president of numerous community organizations, whilst overseeing more than 350 employees at the continuing care retirement community. Interestingly, he has hired more than 30 staff members over the age of 70. Mr Zentz is quick to praise his employees. “Concerning our staff, they show up for work on time, serve as mentors to other employees and have a strong work ethic, our senior employees offer insight based on experience and that makes a tremendous impact on our staff. “As Fellowship Community looks to the future, we will keep our identity as a Christ-Centered organization and will continue to be an independent provider. Our goal is to strengthen our reputation for excellence in senior care by continually exploring and expanding our onsite services for residents based on a medical model with strong psychosocial and spiritual influences.” Under any circumstances and at any level of care, Fellowship Community provides quality memory support. Residents engage in physical and cognitive

22 2017 Healthcare & Pharmaceuticals Awards

activities offered in small groups as well as individualized oneto-one memory care sessions. Programming includes art therapy, music therapy, reminiscent therapy, pet therapy and other varied personal approaches designed to align with the cultural and social patterns of residents it serves. From independent living caregiver support groups to a specialized secure memory support unit, Fellowship Community enhances the lives of residents facing memory challenges. Throughout every level of care, residents are treated with respect and dignity as individuals with unique life experiences and interests. Fellowship Manor is the only nursing care center in the Lehigh Valley and one of two in Pennsylvania to receive PostAcute Care Certification from the Joint Commission. The nursing staff are specially trained to provide clinical care that meets the Joint Commission standards. The rehabilitation staff is highly skilled in physical, occupational and speech therapies that ensure patients reach the highest level of function in the shortest possible time. Regarding the services and programmes it offers, the community provides personalized support, state-of-the-art

equipment and a high staff-toresident ratio encourage the physical, emotional and spiritual well-being of each resident. Physical therapy provides outcomes-oriented interventions to ensure each patient reaches the highest functional level and optimal quality of life. This treatment restores physical independence utilizing evidencebased practices. Treating each patient differently, individualized care for the patient is provided to promote increased strength and coordination, range of motion, and balance while also using a variety of ways to alleviate pain. Occupational therapy improves, develops or restores the sensory, motor, cognitive, perceptual and psychosocial skills that have been impaired by illness or injury. A patient’s individual treatment plans are developed focusing on increasing function through the use of therapeutic activities to increase self-care abilities, joint motion, muscle strength and coordination, enabling the patient to overcome physical, psychological, cognitive and visual limitations through the selective use of assistive devices, and compensatory techniques. Occupational therapy treatment also assists the patient to achieve an optimal level of independent functioning in activities of daily living.


g Best Residential Rehabilitation Facility – Lehigh County

Speech language pathologists evaluate and design therapy programs to improve speech, language, and swallowing functions to increase functional communication skills that include auditory comprehension, speech production, expressive language skills, cognitive/memory abilities and non-verbal communication. Swallowing therapies are designed to establish safe and efficient swallowing of liquids and solid foods to meet nutritional needs. Ultimately, Fellowship Community was founded and is currently operated with the goal of enhancing social, physical, psychological, emotional, intellectual and spiritual well-being at every stage of life. Dedicated to its core values, the Community focuses on showing the love of Christ in everything it does.

Company: Fellowship Community Contact: Kelly Gould Email: KGould@Fellowshipcommunity.com Address: 3000 Fellowship Drive, Whitehall, Pennsylvania, 18052, USA Phone: 001 610 799 3000 ext. 8106 Website: www.fellowshipcommunity.com

2017 Healthcare & Pharmaceuticals Awards 23


HP170024

,

Paediatric Pulmonologist of the Year 2017 - New Jersey Saint Peter’s University Hospital is sponsored by the Roman Catholic Diocese of Metuchen, and acts as a state-designated children’s hospital and a regional perinatal center. We invited Award Winner Archana Singh MD, F.A.A.P to tell us more about her work and how she achieves excellence in every aspect of this. Saint Peter’s Hospital is a major clinical affiliate of Rutgers Biomedical and Health Sciences and an affiliate of The Children’s Hospital of Philadelphia, and works to offer the very highest standards of healthcare service and support to patients from across the New Jersey. Archana talks us through her role at the hospital and some of the recent projects she has undertaken. “Here at Saint Peter’s University Hospital, I work as Chief Pediatric Pulmonologist. Through this role, I work with children who have all types of respiratory disorders, and one of my goals is to reduce hospital admissions in asthmatic children. In order to do this, I have created an Asthma Awareness Action Plan, which is part of home management care. This is an individualized set of guidelines given to each patient and their family, listing their shortacting rescue medication and daily prophylactic medication. It also includes arrangements for follow-up appointments and

environmental control to reduce asthma triggers. They are educated on how to recognize warning symptoms and take the appropriate medicine as needed.

This means the care given to asthmatic pediatric patients meet regulatory guidelines of decreased hospitalizations and shorter duration of stay.”

“Fundamentally, asthma exacerbation is a serious medical issue that increases morbidity in children. One of the challenges pediatricians face is working to establish compliance in their patients. Under my supervision, St. Peter’s University Hospital was a Top Performer on Key Quality Measures for Children’s Asthma Care by the Joint Commission from 2012-2015. The Joint Commission analyzes pediatric admissions from ages 2-18 years old, with asthma as the primary diagnosis, and the percentages that received relievers, systemic corticosteroids, and discharged with a home management plan. The purpose of the Joint Commission is to ensure hospitals are providing the highest quality of care while meeting regulatory requirements to decrease operational costs and shortened lengths of stay.

With regards to the future, Archana is keen to build upon her current success and continue to offer dedicated asthma support that will provide life changing results to her patients, as she is proud to conclude.

24 2017 Healthcare & Pharmaceuticals Awards

“Looking ahead, I would like to expand our asthma education plan to improve quality of life for my patients. My plan includes starting a school outreach program where teachers and nurses can be involved in the care plan to better help the children manage their symptoms. With a comprehensive approach to all aspects of their life, I truly believe patients can effectively handle their asthma diagnosis and have fulfilling lives.”


g Paediatric Pulmonologist of the Year 2017 - New Jersey

Company: Saint Peter Contact: Archana Singh MD, F.A.A.P Email: archanasingh@saintpetersuh.com Address: Saint Peters University Hospital, 254 Easton Ave. MOB-3 ,RN- 3100, 254 Easton Ave. MOB-3 ,RN- 3100, New Brunswick, NJ, 8901, USA Phone: 001 732 565 5467 Website: www.saintpetershcs.com

2017 Healthcare & Pharmaceuticals Awards 25


HP170025

,

Best Provider of Oncology & Pathology Diagnostic Tools – USA & Medical Device CEO of the Year - USA IVDiagnostics is a biotech company dedicated to developing precision diagnostic assays. We invited Frank Szczepanski to tell us about the company’s success and what services it provides. IVDiagnostics work with hospitals and CLIA laboratories that in turn service hospitals and oncologists who are caring for cancer patients. The company’s focus is on metastatic cancer patients, those patients who are at stage two and beyond whereby cancer has spread from the original site to other parts of the body as determined by physicians who determine the stage of cancer. Frank details IVDiagnostic’s overall mission, explaining what the firm hopes to achieve and how it will reach these goals. “Through pre-clinical studies we came to define our focus as metastatic disease. IVDiagnostics provides clinicians with tools to help them better determine the effectiveness of therapy. As a result, we have developed an initial assay for breast cancer patients that

accurately measures the amount of circulating tumor cells (CTCs) in the patient’s blood sample. Within a small amount of blood, the patient may have as little as one cancer cell or thousands. It is important for the physician to know what the level of CTCs is in the patient’s body each time they come for treatment.” Working towards achieving this mission helps IVDiagnostics stand out amongst its competitors. Its technology expertise and subsequent results help the firm mark itself out as the best possible option for clients. Frank points us towards how the assays save lives, before commenting on what he believes is the firm’s most significant breakthrough which has contributed to its overwhelming success. “Here at IVDiagnostics, we have developed technology

for both in-vitro and in-vivo applications. The Rapid version of our in-vitro assay can also capture live, single cancer cells in seconds. These cancer cells can then be diagnosed for genetic mutations providing pathologists and oncologists with additional information. Our assays save lives, improve patient care via earlier detection, and reduce overall cost of patient care throughout the healthcare system. “Concerning our firm’s most significant success to date, I would say it is moving our breast cancer assay forward via a pilot study thus the basis for a pivotal study which will compare our invitro test to our in-vivo test on the same patient.” Discussing recent projects which the company has been working on, Frank mentions its in-vivo device, and observes how this helps not only patients, but doctors as well, as they have been calling out for this technology. This highlights the innovative nature of the company, as it works hard to stay ahead of developments within the industry, something Frank provides a little more detail about. “Recently, we have developed an in-vivo device which can monitor CTCs in a patient’s bloodstream

26 2017 Healthcare & Pharmaceuticals Awards

without taking blood. Within 30-40 minutes, we can scan about 1,000 ml of a patient’s blood or approximately 20% of the blood in your body. The team believe this device is disruptive technology that our medical advisors have been asking for. “Within this ever evolving market, we stay on the forefront of emerging industry developments by leading and anticipating how healthcare is changing. We foresee healthcare moving to remote monitoring of cancer patients and more point-of-care treatment than is currently being done today.” In conclusion, Frank comments on what the future has in store for IVDiagnostics, predicting exciting times ahead if the right decisions and risks are taken. With Frank at the helm, IVDiagnostics can be certain of reaching its goals and targets it sets itself and ultimately, look to become the leader in the healthcare industry. “Looking ahead, there are exciting times ahead for our firm and for the patient monitoring market. The ongoing success of our work depends on finding the right strategic partners who are willing to share risks and rewards with the company and share our mission and vision. This is an invigorating challenge which we look forward to overcoming.”


Best Provider of Oncology & Pathology Diagnostic Tools – USA & Medical Device CEO of the Year - USA

g

Company: IV Diagnostics Inc Contact: Frank Szczepanski Email: frank@ivdiagnostics.com Address: 1440 E. 35th Ave., Suite C235, Gary, IN 46409 Phone: 001 219 840 0007 Website: www.ivdiagnostics.com

2017 Healthcare & Pharmaceuticals Awards 27


HP170028

,

Most Innovative Dental Professional Development Company – UK & Best Dental E-learning Provider – UK ProDental CPD is the UK’s leading organisation for Continuing Professional Development, in compliance and mandatory subjects, for the whole team of dental professionals. We profile the firm to find out more about its service offering. Established in 2007, ProDental CPD offers a cost-effective way of accessing quality CPD to comply with the mandatory requirements set out by the GDC and CQC. The development of its eLearning platform puts it at the forefront of education and eLearning in the 21st century. To support clients and ensure ease of access, ProDental CPD’s innovative website has been designed and built around our customers’ needs. Whether clients are looking for induction courses, compliance or practice management training, the company provides the essential support their company’s needs, and to meet the requirements of their busy workplaces.

This client focus and dedication to providing an innovative, bespoke service, is echoed in the firm’s mission statement: “To deliver high quality education programmes that equip our members with a solid foundation in our philosophy, methods, materials, and interactions needed to create the environment that leads to enriched learning opportunities for every person. We achieve this goal by including comprehensive, innovative lifetime teaching resources with our programmes, by engaging our members in productive, active learning, and by effectively supporting each member’s success with their educational journey.” Drawing on over 10 years’ experience in delivering dental CPD solutions, the firm’s team of dental and learning experts understand the needs of their clients, providing the essential knowledge to underpin its product development and support. What marks the firm out as the best option for clients is its ability to respond and adapt quickly and appropriately to the changing needs of individuals, and the market as a whole. Training is often seen as something that takes staff away from

28 2017 Healthcare & Pharmaceuticals Awards

their workplace and patients. However, eLearning can be accessed anytime and from any location, giving staff more time to be with their patients. For managers, the sourcing and recording of any training that takes place for the staff members can be a relentless and time consuming task. To support them, ProDental CPD’s extensive library of eLearning is designed to provide excellent, cost effective underpinning knowledge for core skills, care and clinical procedure training. The unique practice management interface allows the practice administrator to monitor the progress of all staff completing their required CPD. Additionally, timely reminders will alert staff when a mandatory subject is due for renewal. E-learning is increasing in popularity for a number of reasons, particularly in the healthcare industry, as it offers flexibility, anytime access, and cost effectiveness. Users can choose when they log in and learn at their own pace and the lack of travel reduces costs for the customer. Alongside this, e-learning users have the ability to track their own progress. ProDental CPD supports its users by providing

a CPD/ Reflective Learning log and Training Matrix, along with reminders and alerts to keep members up to date and on schedule with their learning. Continuous improvement is a key aspect of the firm’s success, and as such Pro Dental CPD is committed to continually enhancing its programmes and resources. Therefore, moving forward ProDental CPD is excited to be developing Blended Learning Courses for release very soon. These innovative Blended Learning Courses will provide multiple methods of delivering education by combining online learning with face to face activities.


Most Innovative Dental Professional Development Company – UK & Best Dental E-learning Provider – UK

g

Company: ProDental CPD Ltd Email: info@prohealthcarecpd.com Address: 17 President Buildings, Savile Street East, Sheffield S4 7UQ Telephone: 0114 350 3350 Web Address: www.prodentalcpd.com

2017 Healthcare & Pharmaceuticals Awards 29


HP170015

,

Best Pre-Hospital Care Provider - UK Medicare EMS Group provide medical cover for an array of venues throughout the UK. We profile the company to find out more and learn the secrets behind its success. Established in 2003, Medicare has become the UK’s leading provider of event medical cover. The firm are proud to be one of the most recognised and respected providers in our industry, and each and every member of its team is committed to delivering a patient and client focused approach.

Registered with, and regulated by, the Care Quality Commission, Medicare ensures that clients can rest assured that they are in safe hands when they are treated by this proactive and exemplary company.

Additionally, Medicare strives to improve the efficiency and safety of its clients’ event by working with you to address all aspects of event management. This ensures the safety and enjoyment of everyone participating.

The firm supplies clients with teams of health care professionals dedicated to providing first class pre-hospital care. These teams consist of GMC registered Doctors, HCPC registered Paramedics, IHCD trained Emergency Medical Technicians and fully qualified First Aiders.

Another key aspect of the firm’s service offering is its medical training courses. All of Medicare’s trainers are accredited and hold relevant teaching qualifications; they are experienced to deliver training in their area of expertise to a high standard they are dedicated to delivering consistency and quality to all of the firm’s clients. Finally, Medicare offers an innovative online store stocking a wide variety of first aid supplies to meet any requirement. Competitively priced, the store was created in response to customer feedback, highlighting the firm’s commitment to meeting its clients’ ever evolving needs. Overall, Medicare offers a vast array of services, all provided to the highest possible standard, and moving forward the firm’s ongoing focus will be on providing exceptional services and healthcare solutions that continue to meet its clients’ needs and exceed their expectations.

30 2017 Healthcare & Pharmaceuticals Awards


g

Best Pre-Hospital Care Provider - UK

Company: Medicare EMS Group UK Limited Contact: Matt McDonnell Email: matt@medicare-ems.co.uk Address: South Operation (Head Office), Suffolk Drive, Richmond Road, Dukes Park Industrial Estate, Chelmsford, Essex, CM2 6UN, UK Phone: 03333 011 999 Website: www.medicare-ems.co.uk

+

Medicare EMS Group UK Limited

2017 Healthcare & Pharmaceuticals Awards 31


ghp

Research, Translation, Commercialisation

Subscribe to GHP

Subscribe here www.ghp-magazine.com/subscribe


Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.